Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The supplement may improve hair growth and quality in women with mild to moderate hair loss.

Finasteride reduces hair growth and is safe for women with excessive hair.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

A woman with severe angioedema improved significantly after treatment with rituximab.

Equol may help with antiaging and skin health by boosting collagen and blocking certain hormones.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Contraceptive implants are effective, long-lasting, and safe with manageable side effects.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Antiepileptic drugs can cause side effects like menstrual problems and infertility in women with epilepsy, but most pregnancies result in healthy babies, with newer drugs being safer.

Ixekizumab is safe for long-term use with low rates of major heart-related events.